WebNews
Please enter a web search for web results.
NewsWeb
New Gene-Editing Injection Could Change Heart Disease Treatment
1+ hour, 43+ min ago (262+ words) For many years, people with high cholesterol have relied on daily medicines such as statins to control their condition. Some patients also need regular cholesterol-lowering injections. However, doctors say many people struggle to continue these treatments for life. The new…...
CAR T-cell Therapy Patient Videos Launched
3+ hour, 4+ min ago (356+ words) Two new animated patient information videos designed to help and support UK patients undergoing CAR T-cell therapy have been launched by Sheffield Teaching Hospitals NHS Foundation Trust. The short easy-to-follow videos provide a step-by-step guide to how the treatment works…...
New drug could be game changer for people with high cholesterol - AOL
2+ hour, 49+ min ago (13+ words) New drug could be game changer for people with high cholesterol AOL. com...
Video Experimental drug could treat cholesterol in new way
6+ hour, 33+ min ago (192+ words) ABC News - Breaking News, Latest News and Videos Experimental drug could treat cholesterol in new way The drug, Verve 102, may one day change how high cholesterol is treated through a one-time infusion. VP Vance delivers commencement address at Air Force…...
Excitement and interest as Lp(a) therapies inch closer
2+ hour, 30+ min ago (626+ words) Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected later this year....
Novel CAR T manufacturing process significantly cuts production time
3+ hour, 6+ min ago (514+ words) Efficacy findings comparable to those of existing CAR T cell therapies for relapsed/refractory multiple myeloma (r/r MM). A next-generation manufacturing process can produce a B cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell therapy in less…...
Scribe Therapeutics Presents Late-Breaking Preclinical Data Supporting STX-1150, a Clinical-Stage Epigenetic Silencing Therapy Designed to Achieve Years of LDL-C Lowering After a Single Dose
just now (833+ words) Bio Space Scribe Therapeutics Presents Late-Breaking Preclinical Data Supporting STX-1150, a Clinical-Stage Epigenetic Silencing Therapy Designed to Achieve Years of LDL-C Lowering After a Single Dose - Late-breaking oral presentation at EAS Congress 2026 reports up to 90% PCSK9 reduction and up to 68% LDL-C…...
Pepro Mene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure
7+ hour, 41+ min ago (228+ words) PA Media Pepro Mene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting Pepro Mene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)…...
Experimental drug could treat cholesterol in new way
6+ hour, 33+ min ago (27+ words) Yahoo The drug, Verve 102, may one day change how high cholesterol is treated through a one-time infusion...
Experimental drug could treat cholesterol in new way | GMA
6+ hour, 16+ min ago (78+ words) Experimental drug could treat cholesterol in new way Good Morning America Experimental drug could treat cholesterol in new way The drug, Verve 102, may one day change how high cholesterol is treated through a one-time infusion Up Next in Wellness - /video…...